ClinicalTrials.Veeva

Menu

Left Atrial Volume as Predictor for Arrhythmic Events and CRT Response (iLAV)

O

Ospedale Borgo Trento - Verona

Status

Unknown

Conditions

Left Atrial Volume

Study type

Observational

Funder types

Other

Identifiers

NCT03141606
20140002277

Details and patient eligibility

About

Left atrial volume role for CRT response and for arrhythmic events (VT/VF/AT/AF) onset

Enrollment

230 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with left ventricular ejection fraction ≤ 35%, II, III or IV NYHA Class, even if optimal medical therapy.
  • Patients with standard indication to CRT according current guideline, sinus rhythm at implantation, LBBB and QRS duration >= 120 ms
  • Patients who will undergo to a new CRT-defibrillator system implantation
  • Patients who are able to understand and sign the informed consent
  • Patients who are able to attend all required follow-up visits at the study centerfor 24 months

Exclusion criteria

  • Age < 18 years
  • Women who are pregnant or who are planning to become pregnant
  • Patients with permanent Atrial Fibrillation or persistent Atrial Fibrillation in the 90 days preceding the implantation
  • Patients with organic mitral valve disease
  • Patients with prosthetic heart valves
  • Patients who will undergo to upgrading from other devices (PM or ICD) to CRT, heart transplantation, patients with CRT devices

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems